Current Topics in Medicinal Chemistry

Editor-in-Chief

Allen B. Reitz
Fox Chase Chemical Diversity Center, Inc.
Doylestown, PA
(USA)

Personal Subscription
Become EABM
Become Reviewer



Editorial (Thematic Issue: Structure-Based Drug Design and Combinatorial Chemistry in the Search of Antimitotic Agents) promotion: free to download

Volume:14   Issue: 20
Pp: 2207-2208
Alberto Coelho and Giovanni Marzaro
DOI: 10.2174/1568026614666141130092228

Multicomponent Reactions in Antimitotic Drug Discovery

Volume:14   Issue: 20
Pp: 2209-2230
Angel Cores, Carlos Carbajales and Alberto Coelho
DOI: 10.2174/1568026614666141127115130


New Ligands of the Tubulin Colchicine Site Based on X-Ray Structures

Volume:14   Issue: 20
Pp: 2231-2252
Raquel Alvarez, Manuel Medarde and Rafael Pelaez
DOI: 10.2174/1568026614666141130092637


QSAR and 3D-QSAR Models in the Field of Tubulin Inhibitors as Anticancer Agents

Volume:14   Issue: 20
Pp: 2253-2262
Giovanni Marzaro and Adriana Chilin
DOI: 10.2174/1568026614666141130092853


Target Driven Preclinical Screening for New Antimitotic Chemotherapy Agents

Volume:14   Issue: 20
Pp: 2263-2271
S. Novio, M. Freire-Garabal and M.J. Núnez
DOI: 10.2174/1568026614666141130093425


Natural Products As Antimitotic Agents

Volume:14   Issue: 20
Pp: 2272-2285
Stefano Dall'Acqua
DOI: 10.2174/1568026614666141130095311


KSP Inhibitors as Antimitotic Agents

Volume:14   Issue: 20
Pp: 2286-2311
Concepcion Perez-Melero
DOI: 10.2174/1568026614666141130095532


Epothilones: From Discovery to Clinical Trials

Volume:14   Issue: 20
Pp: 2312-2321
Stefano Forli
DOI: 10.2174/1568026614666141130095855


The Antimitotic Potential of PARP Inhibitors, An Unexplored Therapeutic Alternative

Volume:14   Issue: 20
Pp: 2346-2365
Pablo Iglesias and Jose A. Costoya
DOI: 10.2174/1568026614666141130100641